Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037022 | SCV000060678 | benign | not specified | 2017-07-05 | criteria provided, single submitter | clinical testing | p.Gly384Cys in exon 11 of MYH14: This variant is not expected to have clinical s ignificance, because it has been identified in 1.3% (136/10142) of Ashkenazi Jew ish chromosomes including 1 homozygote by the Genome Aggregation Database (gnomA D, http://gnomad.broadinstitute.org/; dbSNP rs119103280). Although this variant has been reported as a de novo variant in one individual with moderate sensorine ural hearing loss (Donaudy 2004), the evidence is not sufficient to establish ca usality. |
Eurofins Ntd Llc |
RCV000037022 | SCV000331450 | likely benign | not specified | 2016-09-13 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000438830 | SCV000511768 | likely benign | not provided | 2017-01-05 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000438830 | SCV000729165 | likely benign | not provided | 2020-02-21 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27391121, 25262649, 30622556, 15015131, 27884173, 25098841, 30245029, 31898538) |
Genomic Research Center, |
RCV000037022 | SCV000930197 | likely benign | not specified | 2019-04-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000438830 | SCV001102482 | likely benign | not provided | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000438830 | SCV001144619 | likely benign | not provided | 2019-07-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000438830 | SCV001157316 | benign | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000002283 | SCV001296271 | uncertain significance | Autosomal dominant nonsyndromic hearing loss 4A | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV000438830 | SCV003918161 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | MYH14: BS2 |
Molecular Genetics, |
RCV003993731 | SCV004812390 | likely benign | Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome | 2023-05-04 | criteria provided, single submitter | clinical testing | European Non-Finnish population allele frequency is 0.3994% (rs119103280, 511/127.956 alleles, 1 homozygotes in gnomAD v2.1). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.5.1, this variant is classified as LIKELY BENIGN. Following criteria are met: BS1 |
OMIM | RCV000002283 | SCV000022441 | pathogenic | Autosomal dominant nonsyndromic hearing loss 4A | 2004-04-01 | no assertion criteria provided | literature only | |
Clinical Genetics, |
RCV000438830 | SCV001920105 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000438830 | SCV001970131 | likely benign | not provided | no assertion criteria provided | clinical testing |